Regulation News: Breaking Regulation News, Comments and Articles. - Page: 3

15:50 EST 20th December 2014 | BioPortfolio

Regulation News - Page: 3RSS

Read the latest Regulation News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Regulation.

Search or Follow Our Regulation - Page: 3 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Regulation - Page: 3 News.

Showing "regulation regulatory" News Articles 51 to 75 of 7,400+

Thursday 18th December 2014

Public Ranks Nurses as Most Honest, Ethical Profession for 13th Straight Year

SILVER SPRING, Md., Dec. 18, 2014 /PRNewswire-USNewswire/ -- As the American Nurses Association (ANA) embarks on a yearlong campaign to highlight the importance of nursing ethics and their impact on patients and health care quality, the annual Gallup survey on trust in professions shows the public continues to rate nursing as the most honest and ethical. For the past 13 years, the public has vote...

Cellectis Plant Sciences and Two Blades Foundation Announce the Execution of a Cross-License Agreement on TAL Effector Nuclease Technologies

Regulatory News: Cellectis (Paris:ALCLS): Cellectis plant sciences, a Minnesota-based company focusing on developing healthier food products, and the Two Blades Foundation (2Blades) today announced the execution of a non-exclusive cross-license agreement relating to TAL nuclease technologies. Pursuant to the agreement, 2Bl...

ISN Releases Third Edition of US Contractor Health & Safety Performance Indicators Publication Series

DALLAS, Dec. 18, 2014 /PRNewswire/ -- ISN has released its third annual U.S. Health & Safety Performance Indicators publication series. With data aggregated from over eight billion U.S. work hours of activity reported in 2013 within its online contractor management platform, ISNetworld, this three-part series provides contractor health and safety key performance indicator (KPI) statistics...

Highest EU Court To Interpret Cosmetic Animal-Test Ban’s Scope

The European Federation for Cosmetic Ingredients awaits a ruling from the European Court of Justice – expected in about two years – as to whether the ban in the EU necessarily prohibits the marketing of cosmetic ingredients tested on animals to m...

IMS Institute Identifies Innovative Payment Models for Pharmaceuticals at Forbes Healthcare Summit

Advances Discussion on How Big Data Can Drive Understanding of Patient Treatment, Costs and Outcomes New approaches for determining how much drugs should cost, and for setting the price for innovative treatments, were highlighted in a keynote presentation by Murray Aitken, IMS Health senior vice president and executive director of the IMS Institute for...

Amneal Pharmaceuticals, LLC Selects Revitas Revenue Management Suite

Revitas, Inc., the leading provider of integrated solutions for contract, revenue, and compliance management, today announced that Amneal Pharmaceuticals (A

Protein quality control at the inner nuclear membrane

The nuclear envelope is a double membrane that separates the nucleus from the cytoplasm. The inner nuclear membrane (INM) functions in essential nuclear processes including chromatin organization and regulation of gene expression. The outer nuclear m...

Praxair Surface Technologies Introduces Advanced REACH-Compliant, Chrome-Free Coatings for Aviation and Industrial Turbines

Praxair, Inc. (NYSE: PX), today announced the introduction of a new line of chromium (VI)-free ceramic aluminum coatings for the aerospace and power generation industries. Praxair Surface Technologies’ new line of slurries sustainably produces coatings with the same high performance of legacy chrome-containing coatings. The company’s SermeTel...

Enzyme regulation: A thiol switch opens the gate

AAA+ proteases are quality control machineries consisting of substrate-binding ATPase modules for protein unfolding and a proteolytic chamber. New research now shows a redox switch in the Escherichia coli Lon protease that controls this process, wide...

Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023

BURLINGTON, Mass., Dec. 18, 2014 /PRNewswire/ -- Decision Resources Group finds that the Asia Pacific dental biomaterial market will grow moderately through 2023 as the aging population, increasing adoption of dental implant procedures and growing awareness of dental biomaterials all spur procedure volumes. Growth will be particularly rapid in underdeveloped markets such as China and India, w...

Molex Highlighted its Pioneering Technologies for the Latest MedTech Devices at BIOMEDevice

Company showcased a wide range of advanced electronic solutions Molex Incorporated showcased its technical innovations at BIOMEDevice (an MD&M event), San Jose, CA, December 3 – 4, 2014. The company has proven expertise in developing solutions that help medical device manufacturers bring their emerging technologies to market in applications such ...

Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors

TiFiber’s patented antimicrobial polymers (AMPs) are safer, more effective alternatives to widely used antimicrobials in personal care and medical products. Fayetteville, Arkansas (PRWEB) December 18, 2014 Today, TiFiber, Inc. announced its plans to locate its pilot production facility and future company headquarters in Fort Smith, Arkansas to further develop and produce innovative new material...

Industry Expert David Schneider Joins Comprehend Board of Directors

Comprehend today announced that David Schneider, Chief Revenue Officer at ServiceNow, has joined the company as a member of its Board of Directors. Schneider brings more than 20 years of international sales and business development experience in the technology space. The sales executive has deep experience with startups and disrupting well-establi...

Medicure Announces Change in Fiscal Year End and Provides One-Time Guidance on Quarterly Revenue

WINNIPEG, Dec. 18, 2014 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTCQB:MCUJF), a specialty pharmaceutical company, today announced that the Board of Directors has approved a change in the Company's fiscal year end to December 31. The change will result in a stub period from June 1, 2014, to December 31, 2014, and as a result of the change, the first full fiscal year wi...

Technip to Acquire Zimmer from Air Liquide

French engineering contractor Technip has announced plans to acquire Air Liquide's Zimmer polymer technology business based at Frankfurt, Germany, by the end of 2014, pending all regulatory approvals. A purchase price was not revealed.

CannLabs Joins The Association of Responsible Cannabis Public Companies, Inc.

CannLabs becomes a Founding Member of ARCPC Denver, Colorado (PRWEB) December 18, 2014 CannLabs, Inc. (OTCQB: CANL,) the leading provider of proprietary, cloud-based analytics and scientific testing methodologies relating to cannabis, announced today it has joined the Association of Responsible Cannabis Public Companies, Inc. (the ARCPC), as one of the organization's first three members, Can...

KCR Acquires Project Portfolio from Ukrainian CRO AXIS

The enterprising European Contract Research Organization expands its operations in Ukraine KCR, a European Contract Research Organization (CRO), has recently acquired the whole portfolio of clinical projects from the Ukrainian CRO, AXIS Group Ltd. The acquisition of AXIS trials further strengthens KCR’s presence in Ukraine making the country the most...

WIL IT software deal speed up US FDA drug evaluations? Yes says Instem

Regulatory reviewers spend more time managing incoming data than on the drug evaluation process, says Instem which has inked a deal with WIL Research for its nonclinical IT systems.

CBRE Group, Inc. Healthcare Practice Achieves Strong Growth in 2014

CBRE Group, Inc. (NYSE:CBG) today announced that its healthcare specialty group achieved strong growth in 2014, with 14 long-term contracts signed this year, including six with new clients. Leading healthcare organizations that selected CBRE to provide long-term real estate services for their portfolios included Bon Secours Health System and Memor...

Pfizer Reports Top-Line Results From a Phase 3 Study Evaluating Pregabalin Controlled-Release Formulation as a Treatment for Patients With Postherpetic Neuralgia

Pfizer Inc. (NYSE:PFE) announced today top-line results from a double-blind Phase 3 study evaluating pregabalin controlled-release (CR) formulation in adult patients with postherpetic neuralgia (pain after shingles or PHN). The results show that pregabalin CR resulted in a statistically significant positive effect compared to placebo in the primary endpoin...

Cambridge Semantics Adds Keylines Network Visualization Tool to Deliver New Clarity to Big Data Analytics

Pharma and Financial Services Companies Can Gain “Big Picture” Insights and Business Answers with Combined Data Graphing Tool and Anzo Smart Data Platform CAMBRIDGE, Mass. (PRWEB) December 18, 2014 Cambridge Semantics, the leading provider of smart data solutions driven by Semantic Web technology, today announced the integration of its Anzo Smart Data Platform (Anzo SDP) with the KeyLines net...

Antibe Therapeutics Announces Appointment of Canadian Rheumatologist J. Carter Thorne to Its Clinical Advisory Board

Antibe Therapeutics Inc. (“Antibe” or the “Corporation”) (TSXV:ATE; OTCQX:ATBPF) is pleased to announce the expansion of its Clinical Advisory Board with the appointment of Canadian rheumatologist J. Carter Thorne, MD, FRCP(C), FACP, Chief of the Division of Rheumatology and Director of The Arthritis Program at Southlake Regional Health Centre in N...

Ambulance and Emergency Equipment: Global Markets

    LONDON, Dec. 18, 2014 /PRNewswire/ -- The ambulance equipment industry experienced significant growth during the last decade due to the recession, an unstable health insurance environment, natural calamities and technological advancements. This BCC Research report analyzes present and future strategies within various segments of the ambulance and emergency medical serv...

Merck Acquires OncoEthix, a Privately Held Oncology Company Developing Novel BET Inhibitors for Hematological and Solid Cancers

Acquisition Expands Merck’s Oncology Portfolio with Novel Oral BET Inhibitor, OTX015 Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that it has acquired, through a subsidiary, OncoEthix, a Swiss-based privately held biotechnology company specializing in oncology drug development. Through the acquisition, Merck ha...

US Government Payer Reimbursement: Three Keys to Success

By Sarah Ray, Senior Research Analyst Attaining US government payer reimbursement is not always easy for life sciences organizations.  Facing evolving regulatory expectations, companies can get bogged down with the details when mapping out their pla...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks